Zevra Therapeutics, Inc. (ZVRA) NASDAQ
Currency In USD
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
AD
Currency In USD
| Market Cap | 495.59M |
| Enterprise Value | 496.39M |
| P/E Ratio | 5.8 |
| PEG Ratio | 0 |
| Price/Sales Ratio | 6.12 |
| Price/Book Ratio | 3.59 |
| Enterprise/Revenue | 5.34 |
| Enterprise/EBITDA | 4.65 |
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
| Profit Margin | 1.02 |
| Operating Margin | -0.4 |
| Return On Assets | 0.45 |
| Return On Equity | 0.81 |
| Revenue | 106.47M |
| Revenue/Share | 2.09 |
| Gross Profit | 89.99M |
| EBITDA | 98.71M |
| Net Income | 83.23M |
| Diluted EPS | 1.35 |
| Total Cash | 95.6M |
| Total Cash/Share | 1.64 |
| Total Debt | 1.15M |
| Total Debt/Equity | 0.01 |
| Current Ratio | 4.89 |
| Book Value Per Share | 3.52 |
| 52-Week Change | 40.56 |
| 52-Week High | 14.27 |
| 52-Week Low | 7.16 |
| Moving Average 50 Days | 11.01 |
| Moving Average 200 Days | 9.61 |
| Average Volume | 1.47M |
| Shares Outstanding | 59.12M |
| % Held by Institutions | 74.7 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:16 |
| Last Split Date | December 28, 2020 |